-
- SEGAWA Tohru
- Department of Surgery, National Murayama Hospital
Bibliographic Information
- Other Title
-
- 肝細胞癌の治療up‐to‐date
- カン サイボウガン ノ チリョウ up-to-date
Search this article
Description
Current treatment of hepatocellular carcinoma (HCC) was reported. Small HCC can be detected by the close follow-up of the patients with chronic liver disease using diagnostic modalities, such as US, CT and serum tumor marker (AFP, PIVKA-II) measurements. Recent improvements in surgical techniques and preoperative and postoperative managements have increased the safety of hepatic resection. Consequently, the long-term survival following hepatectomy in patients with HCC have remarkably improved as well. While the development of non-surgical therapeutic procedures, such as transcatheter arterial embolization (TAE), percutaneous ethanol injection therapy (PEIT), microwave coagulation therapy (MCT) and radiofrequency ablation (RFA) have changed the indication for hepatic resection of HCC, early diagnosis and aggressive treatments for postoperative recurrence and second primary HCC still remains the most important strategy in prolonging the survival.
Journal
-
- Japanese Journal of National Medical Services
-
Japanese Journal of National Medical Services 55 (5), 203-211, 2001
Japanese Society of National Medical Services
- Tweet
Details 詳細情報について
-
- CRID
- 1390282681289350272
-
- NII Article ID
- 130004315958
- 40019863075
-
- NII Book ID
- AN00017113
-
- ISSN
- 18848729
- 00211699
-
- NDL BIB ID
- 024995176
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- CiNii Articles
-
- Abstract License Flag
- Disallowed